A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Enzalutamide
Related studies linked through entity extraction aliases.
A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
An Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Chinese Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan
- Status
- COMPLETED
- Phase
- N/A
PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNA
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Erdafitinib and Abiraterone Acetate or Enzalutamide in Treating Patients With Double Negative Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).
- Status
- COMPLETED
- Phase
- PHASE2
Effect of a Reduced Dose Enzalutamide in Frail (m)CRPC Patients on Cognitive Side Effects
- Status
- COMPLETED
- Phase
- PHASE4
Pan Tumor Rollover Study
- Status
- RECRUITING
- Phase
- PHASE2
Descriptive Analysis of Clinical Outcomes in Patients With Prostate Gland Cancer, Which Spreads to Other Parts of the Body, Who Were Treated First With Novel Anti-hormone Therapy Followed by a Second Line Treatment With Novel Anti-Hormone Therapy or RadIum-223 (Xofigo).
- Status
- COMPLETED
- Phase
- N/A
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
- Status
- TERMINATED
- Phase
- PHASE1
Neoadjuvant Androgen Deprivation Therapy Combined With Enzalutamide and Abiraterone Using Multiparametric MRI and 18FDCFPyL PET/CT in Newly Diagnosed Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Status
- TERMINATED
- Phase
- PHASE3
Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)
- Status
- COMPLETED
- Phase
- PHASE3
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Combination of Entinostat and Enzalutamide in Advanced Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study Evaluating Enzalutamide Pharmacokinetics and Pharmacodynamics, and Related Changes After Drug Switch
- Status
- COMPLETED
- Phase
- PHASE1